Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell mediated lysis of triple-negative breast cancer cells
Fingerprint
Dive into the research topics of 'Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell mediated lysis of triple-negative breast cancer cells'. Together they form a unique fingerprint.